Atossa Genetics Inc Stock
Atossa Genetics Inc Stock
Atossa Genetics Inc dominated the market today, gaining €0.046 (3.230%).
Currently there is a rather positive sentiment for Atossa Genetics Inc with 5 Buy predictions and 1 Sell predictions.
With a target price of 3 € there is potential for a 103.8% increase which would mean more than doubling the current price of 1.47 € for Atossa Genetics Inc.
So far the community has only identified positive things for Atossa Genetics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Atossa Genetics Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atossa Genetics Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Atossa Genetics Inc | 3.230% | 11.232% | -12.836% | 144.597% | 51.541% | -21.215% | -61.912% |
InVivo Therapeutics Holdings | 0.630% | 0.000% | 73.160% | -71.979% | -53.488% | -99.932% | -99.966% |
Star Equity Holdings Inc. | 1.260% | 2.548% | -0.617% | 23.846% | -14.362% | -66.736% | -87.766% |
Medmira Inc. | - | 8.235% | -7.071% | -19.298% | -29.231% | - | - |
Comments
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat